Related Experiment Videos

Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic

B Lelongt1, S Bengatta, M Delauche

  • 1Institut National de la Santé et de la Recherche Médicale, Unité 489, Hôpital Tenon and Université Pierre et Marie Curie (Paris 6), 75020 Paris, France. brigitte.lelongt@tnn.ap-hop-paris.fr

Insights

Matrix metalloproteinase (MMP)9 deficiency unexpectedly worsened anti-glomerular basement membrane nephritis in mice. MMP9 normally degrades fibrin, preventing its accumulation and protecting against glomerular injury.

Area of Science:

  • Nephrology
  • Immunology
  • Biochemistry

Background:

  • Matrix metalloproteinase (MMP)9 is elevated in various kidney diseases.
  • Its precise role in nephropathies, particularly anti-glomerular basement membrane nephritis, remains unclear.

Purpose of the Study:

  • To investigate the role of MMP9 in the pathogenesis of anti-glomerular basement membrane nephritis using a genetic approach.
  • To determine if MMP9 deficiency influences the severity of glomerular injury mediated by fibrin.

Main Methods:

  • Utilized a genetic approach with adult MMP9-deficient (MMP9(-/-)) mice.
  • Induced an accelerated model of anti-glomerular basement membrane nephritis.
  • Assessed renal histology, function (serum creatinine, albuminuria), and fibrin deposition.

Main Results:

  • MMP9(-/-) mice exhibited more severe nephritis than control (MMP9(+/+)) mice.
  • Increased serum creatinine, albuminuria, glomerular crescents, and fibrin deposition were observed in MMP9(-/-) mice.
  • Fibrin accumulation in glomeruli was significantly higher in MMP9(-/-) mice, indicating fibrin is a critical substrate for MMP9.

Conclusions:

  • MMP9 plays a protective role in the development of fibrin-induced glomerular lesions.
  • MMP9 is essential for degrading fibrin, thereby preventing its pathological accumulation in the glomeruli during nephritis.

Related Concept Videos